Eczema: Experimental drug shows promise in treating atopic dermatitis

New Research Sheds Light on Why Eczema So Often Begins in Childhood

Major Depressive Disorder Shares Immune Abnormalities and Potential Therapeutic Targets With Inflammatory Skin Diseases, According to New Study

Mount Sinai Unveils New State-of-the-Art Facility for Dermatology Patients on Manhattan’s West Side

Mount Sinai Dermatologist Reports Phase 3 Success for Rocatinlimab in Moderate-to-Severe Eczema

Mount Sinai to Receive $5 Million Gift From the Asness Family to Advance Eczema and Allergy Research and Treatment

Mount Sinai Dermatologists Use Tape Strips to Map Immune Changes in Common Skin Disease

Mount Sinai Study Finds Long-Term Eczema Treatment Benefits Patients With Delayed Response

Mount Sinai Dermatologists Show Promising Results Using Combination Therapy for Vitiligo Patients

Mount Sinai Experts Author Landmark ‘Seminar’ on Atopic Dermatitis (Eczema) in The Lancet

‘Follow the science and follow your gut’ to make a change in medicine

Mount Sinai Secures Over $4 Million Grant From National Institutes of Health to Study Alopecia Areata and Atopic Dermatitis in People With Down Syndrome